Robotic Surgery in Adult Spine Deformity
Robotic Assisted Minimal Invasive Surgery in Adult Spine Deformity
Adult spinal deformity (ASD) significantly impacts quality of life through chronic low back pain and/or spinal imbalance, impairing the ability to walk independently in patients both with and without spinal cord injury (SCI). In particular, the importance of sagittal balance of the spine and its correlation with outcome in the bipedal population are well established. Despite extensive efforts to integrate knowledge about sagittal parameters of the spine into surgical planning, there are still debates on which set of biomechanical parameters should be focused on to achieve the optimal surgical result for the individual patient.
Unique IDentifier (UniD) Adaptive Spine Intelligence (ASI, Medtronic) makes spine surgery predictable and repeatable using artificial intelligence - backed by data science. Pre-operative planning with the integration of artificial intelligence mitigates the risk of surgical and realignment failure as well as revision surgery. Once the surgical plan has been decided on, the achievement of the surgical goal is directly related to surgical performance. Here, the placement of screws into the vertebral bodies is one of the main surgical steps in ASD surgery. Thanks to technical developments, the process of screw placement has advanced from conventional X-ray-guided and/or freehand techniques to navigated and robot-assisted techniques. In particular, the safety and reproducibility of screw placement have been claimed to be superior when using robotic assistance.
In the present investigation, the primary objective is to evaluate the feasibility of software-based planning using the UniD ASI software in conjunction with robotic assistance and prebent rods during ASD surgeries with a focus on minimally invasive strategies for deformity correction. The secondary objective is to investigate both patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs). The hypothesis is that both software planning with the integration of artificial intelligence and robot-assisted minimally invasive surgeries provide a safe, reproducible, and significant improvement in clinical outcome in ASD patients.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Michael Fiechter, MD, PhD
- Phone Number: 0041419395788
- Email: michael.fiechter@paraplegie.ch
Study Contact Backup
- Name: Tobias Pötzel, MD
- Phone Number: 0041419395788
- Email: tobias.poetzel@paraplegie.ch
Study Locations
-
-
-
Nottwil, Switzerland, 6207
- Recruiting
- Swiss Paraplegic Center, Spine Surgery
-
Contact:
- Michael Fiechter, MD, PhD
- Phone Number: 0041419395788
- Email: michael.fiechter@paraplegie.ch
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
The study population includes patients suffering from adult spine deformity (ASD) and who have routinely been selected to undergo deformity correction surgery with robotic and/or artificial intelligence (AI) assistence (UniD).
Description
Inclusion Criteria:
- Age ≥18 years
- Patients undergoing or who have undergone surgical correction of adult spine deformity (ASD, within the cone of economy) at the Swiss Paraplegic Center (SPC) in Nottwil, Switzerland, with and without spinal cord injury (SCI)
- Robotic and/or artificial intelligence assisted spine surgery
- Signed general consent form
Exclusion Criteria:
- Patients with documented pathologies impairing radiologic interpretation of data sets, e.g. active tumors affecting structural integrity of the spine, uncontrolled infections of the spine, documented congenital deformities of the spine
- Insufficient availability of clinical and/or imaging data necessary for further investigation
- Refusal of general consent or missing general consent form
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Adult spine deformity (ASD) patients
|
Deformity correction surgery in patients suffering from adult spine deformity (ASD) according to Minimally Invasive Spinal Deformity Surgery Algorithm 2 (MISDEF-2) criteria and with the use of robotic and/or artificial intelligence (Unique IDentifier, UniD) assisted spine surgery. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of robotic / artifical intelligence (AI)-assisted surgery
Time Frame: From enrollment to the end of follow-up (2 years after deformity surgery).
|
The primary objective is to evaluate the feasibility of software-based planning using the Unique IDentifier (UniD) Adaptive Spine Intelligence (ASI, Medtronic) software in conjunction with robotic assistance and prebended rods during adult spine deformity (ASD) surgeries with a focus on minimal invasive strategies for deformity correction in patients with and without spinal cord injury (SCI). |
From enrollment to the end of follow-up (2 years after deformity surgery).
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient reported outcome measures
Time Frame: From enrollment to the end of follow-up (2 years after deformity surgery).
|
The secondary objective is to investigate both patient reported outcome measures (PROMs) and patient reported experience measures (PREMs). |
From enrollment to the end of follow-up (2 years after deformity surgery).
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Michael Fiechter, MD, PhD, Swiss Paraplegic Center, Spine Surgery, Nottwil, Switzerland
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- 2026-00088
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
The data collected in this study are not publicly available due to restrictions under national data protection legislation. Fully anonymised data may be made available upon reasonable request, subject to approval by the local ethics committee (Ethikkommission Nordwest- und Zentralschweiz, EKNZ). The principal investigator may be contacted for guidance concerning such a data request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.